Rxo (RXO) Cash from Financing Activities (2021 - 2025)
Rxo's Cash from Financing Activities history spans 5 years, with the latest figure at -$3.0 million for Q3 2025.
- For Q3 2025, Cash from Financing Activities fell 100.28% year-over-year to -$3.0 million; the TTM value through Dec 2025 reached $1.0 million, down 99.91%, while the annual FY2025 figure was $1.0 million, 99.91% down from the prior year.
- Cash from Financing Activities reached -$3.0 million in Q3 2025 per RXO's latest filing, roughly flat from -$3.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.1 billion in Q3 2024 to a low of -$145.0 million in Q4 2022.
- Average Cash from Financing Activities over 5 years is $48.8 million, with a median of -$3.5 million recorded in 2023.
- Peak YoY movement for Cash from Financing Activities: crashed 417.86% in 2022, then soared 27225.0% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$28.0 million in 2021, then plummeted by 417.86% to -$145.0 million in 2022, then soared by 31.03% to -$100.0 million in 2023, then soared by 101.0% to $1.0 million in 2024, then plummeted by 400.0% to -$3.0 million in 2025.
- Per Business Quant, the three most recent readings for RXO's Cash from Financing Activities are -$3.0 million (Q3 2025), -$3.0 million (Q2 2025), and $7.0 million (Q1 2025).